Biosig Net Cash Flow from Operations from 2010 to 2024
| BSGM Stock | USD 1.32 0.16 10.81% |
Check Biosig Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biosig main balance sheet or income statement drivers, such as Depreciation And Amortization of 379.1 K, Interest Expense of 2.6 K or Selling General Administrative of 19.1 M, as well as many exotic indicators such as Price To Sales Ratio of 2 K, Dividend Yield of 2.0E-4 or Days Sales Outstanding of 511. Biosig financial statements analysis is a perfect complement when working with Biosig Technologies Valuation or Volatility modules.
Biosig | Net Cash Flow from Operations |
About Biosig Technologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Biosig Technologies income statement, its balance sheet, and the statement of cash flows. Biosig Technologies investors use historical funamental indicators, such as Biosig Technologies's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although Biosig Technologies investors may use each financial statement separately, they are all related. The changes in Biosig Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biosig Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Biosig Technologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Biosig Technologies. Please read more on our technical analysis and fundamental analysis pages.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biosig Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biosig Technologies' short interest history, or implied volatility extrapolated from Biosig Technologies options trading.
Pair Trading with Biosig Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biosig Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosig Technologies will appreciate offsetting losses from the drop in the long position's value.Moving against Biosig Stock
| 0.77 | THMO | Thermogenesis Holdings Financial Report 20th of May 2024 | PairCorr |
| 0.73 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
| 0.58 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
| 0.54 | RCM | R1 RCM Inc Financial Report 2nd of May 2024 | PairCorr |
| 0.53 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
The ability to find closely correlated positions to Biosig Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biosig Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biosig Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biosig Technologies to buy it.
The correlation of Biosig Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biosig Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biosig Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biosig Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Biosig Technologies Correlation against competitors. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Biosig Stock analysis
When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.91) | Return On Assets (6.03) | Return On Equity (59.77) |
The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.